Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
12.34
-0.27 (-2.14%)
Nov 13, 2026, 3:00 PM CST
SHA:600129 Revenue
Chongqing Taiji Industry(Group) Co.,Ltd had revenue of 2.09B CNY in the quarter ending September 30, 2026, a decrease of -13.93%. This brings the company's total for the last twelve months to 9.59B, down -4.50% year-over-year. In the year 2025, Chongqing Taiji Industry(Group) Co.,Ltd had annual revenue of 10.50B, down -15.23%. That makes Chongqing Taiji Industry(Group) Co.,Ltd the 6,173rd largest company in the world by revenue and 843rd in China.
Revenue (ttm)
9.59B
Revenue Growth
-4.50%
P/S Ratio
0.71
Revenue / Employee
882.59K
Employees
10,864
Market Cap
6.80B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600129 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.50B | -1.89B | -15.23% |
| Dec 31, 2024 | 12.39B | -3.24B | -20.72% |
| Dec 31, 2023 | 15.62B | 1.50B | 10.58% |
| Dec 31, 2022 | 14.13B | 1.98B | 16.28% |
| Dec 31, 2021 | 12.15B | 941.63M | 8.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Beijing Foyou Pharma CO.,LTD | 3.61B |
| Zhejiang Tianyu Pharmaceutical | 3.58B |
| Renhe Pharmacy Co.,Ltd | 3.49B |
| Jiangsu Kanion Pharmaceutical | 3.37B |
| Jiuzhitang | 2.79B |
| Sunflower Pharmaceutical Group | 2.75B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 1.90B |
| Ningbo Menovo Pharmaceutical | 1.83B |